Abstract:(Cancer Cell 19, 541–555; April 12, 2011) It has come to our attention that an error was made in the assembly of Figures 3D, 3E, 5E, 5F , and Figure S7H, resulting in the incorporation of incorrect representative images in these figures. We also note an error in Table 1 that leads to the inclusion of incorrect data in lines 3 and 4. The corrected figures and Table 1 are shown below. A corrected version of the online supplemental data is now available online at doi:10.1016/j.ccr.2011.02.006. Importantly, we note that the oversight has no bearing on the conclusions of the study and we apologize for any potential confusion caused by these errors.Figure 5CCL18 Induces Functional Response in PITPNM3 Expressing HEK293 CellsView Large Image Figure ViewerDownload Hi-res image Download (PPT)Table 1Correlation of CCL18 Expressing TAM Counts with Clinicopathological Status in 562 Cases of Patients with Breast CancerCCL18+ TAM counts≤56-20>20p valueAge(years)≤451138784>4511886740.716Tumor size (cm)≤21267569>210698880.044Stage 046101 I73131 II1079792 III65363<0.001Histological gradeaGrading in 505 cases of invasive ductal carcinoma. I454617 II726064 III6957750.002MetastasisbDistant metastasis identified during postoperative follow-up. Lung247 Liver01312 Bone42527 Brain1370.014Lymph Node Metastasis 01653317 1- 3588470 ≥495670<0.01LVI (+)326191 (-)20011266<0.001ER (+)162129120 (-)7044370.31Her2 (+)342541 (-)1971471170.007CCL5 (-)594445 (+)615339 (++)684735 (+++)4428390.364CD4+ T LymphocytescPercent volume of CD4+/CD8+ T lymphocytes. Low905846 Media885753 High5458580.036CD8+ T LymphocytescPercent volume of CD4+/CD8+ T lymphocytes. Low854955 Media746658 High7357450.414See also Tables S1–S3.a Grading in 505 cases of invasive ductal carcinoma.b Distant metastasis identified during postoperative follow-up.c Percent volume of CD4+/CD8+ T lymphocytes. Open table in a new tab See also Tables S1–S3. CCL18 from Tumor-Associated Macrophages Promotes Breast Cancer Metastasis via PITPNM3Chen et al.Cancer CellApril 12, 2011In BriefTumor-associated macrophages (TAMs) can influence cancer progression and metastasis, but the mechanism remains unclear. Here, we show that breast TAMs abundantly produce CCL18, and its expression in blood or cancer stroma is associated with metastasis and reduced patient survival. CCL18 released by breast TAMs promotes the invasiveness of cancer cells by triggering integrin clustering and enhancing their adherence to extracellular matrix. Furthermore, we identify PITPNM3 as a functional receptor for CCL18 that mediates CCL18 effect and activates intracellular calcium signaling. Full-Text PDF Open Archive

CCL18/PITPNM3 Enhances Migration, Invasion, and EMT Through the NF-κB Signaling Pathway in Hepatocellular Carcinoma

Overexpression of PITPNM3 Promotes Hepatocellular Carcinoma Cell Metastasis

The LINC00152/miR-205-5p/CXCL11 Axis in Hepatocellular Carcinoma Cancer-Associated Fibroblasts Affects Cancer Cell Phenotypes and Tumor Growth.

CXCL3 contributes to CD133 + CSCs maintenance and forms a positive feedback regulation loop with CD133 in HCC via Erk1/2 phosphorylation

Integrin α1β1 and α2β1 Are the Key Regulators of Hepatocarcinoma Cell Invasion Across the Fibrotic Matrix Microenvironment

CXCR2/CXCL5 Axis Contributes to Epithelial–mesenchymal Transition of HCC Cells Through Activating PI3K/Akt/GSK-3β/Snail Signaling

Effect on Invasion and Migration of Migration of Mitofusion-2 Overexpression to Phosphatidylinositol Transfer Membrane-Associated Protein 3-Positive Hepatoma Cell Line SMMC-7721

CXCR2/CXCL5 axis contributes to epithelial-mesenchymal transition of HCC cells through activating PI3K/Akt/GSK-3β/Snail signaling.

CCL18 from Tumor-Associated Macrophages Promotes Breast Cancer Metastasis Via PITPNM3

Chemokine CCL3 facilitates the migration of hepatoma cells by changing the concentration intracellular Ca<sup>2+</sup>

CCL16 is a pro-tumor chemokine that recruits monocytes and macrophages to promote hepatocellular carcinoma progression

Hpcl3s Promotes Hepatocellular Carcinoma Metastasis by Activating Β-Catenin Signaling.

CCL18 Promotes the Metastasis of Squamous Cell Carcinoma of the Head and Neck Through MTDH‐NF‐κB Signalling Pathway

EIF3B affects the invasion and metastasis of hepatocellular carcinoma cells via the TGFBI/MAPK/ERK pathway

Cc Chemokine Ligand 18(ccl18) Promotes Migration and Invasion of Lung Cancer Cells by Binding to Nir1 Through Nir1-Elmo1/Doc180 Signaling Pathway

Cancer-associated Fibroblasts Promote Hepatocellular Carcinoma Metastasis Through Chemokine-Activated Hedgehog and TGF-β Pathways.

LINC01419-mediated epigenetic silencing of ZIC1 promotes metastasis in hepatocellular carcinoma through the PI3K/Akt signaling pathway

Paracrine Effects of CCN3 from Non-Cancerous Hepatic Cells Increase Signaling and Progression of Hepatocellular Carcinoma

IFITM3 influences the invasion and metastasis of hepatocellular carcinoma by regulating NCAPG through phosphorylation

Cancer associated fibroblast-derived CCL5 promotes hepatocellular carcinoma metastasis through activating HIF1/ZEB1 axis

Ccr6(+) B Lymphocytes Responding to Tumor Cell-Derived Ccl20 Support Hepatocellular Carcinoma Progression Via Enhancing Angiogenesis